Ensuring Access to Essential Drugs Act
Introduced Mar 6, 2025 by Rep. Andrew R. Garbarino
It's waiting on a committee vote to reach the full chamber. Most bills never leave this stage.
This bill exempts certain brand-name drugs from the Medicare Part D Manufacturer Discount Program. Under the program, drug manufacturers provide discounts to beneficiaries who have incurred costs above the annual deductible under the Medicare prescription drug benefit.
Specifically, the bill exempts from the program orally administered, brand-name drugs that are considered generics for purposes of the Medicaid Drug Rebate Program (per an exception granted by the Centers for Medicare & Medicaid Services).
Summary by the Congressional Research Service.
No floor votes yet — it hasn't reached the floor of either chamber.